Volume 67, Issue 1, Pages (January 2005)

Slides:

Advertisements

Similar presentations

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Volume 69, Issue 1, Pages (January 2006)

Nina Vasavada, Rajiv Agarwal Kidney International

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases Gerhard Lonnemann, Johannes Duttlinger,

Volume 54, Issue 2, Pages (August 1998)

Beta blockers in the management of chronic kidney disease

Anemia management in chronic kidney disease

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Demetrios J. Kutsogiannis, R.T.Noel.

Reassessment of the care of the patient with chronic kidney disease

The risk of hospitalization and modality failure with home dialysis

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

Francesco Paolo Schena Kidney International

Retrospective study of CMV retinitis in patients with AIDS

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 74, Issue 12, Pages (December 2008)

Volume 70, Pages S21-S25 (December 2006)

N-terminal pro B-type natriuretic peptide (NT pro-BNP) is a predictor of long-term survival in male patients of 75 years and older with high-grade asymptomatic.

Volume 55, Issue 1, Pages (January 1999)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 70, Issue 11, Pages (December 2006)

Volume 77, Issue 2, Pages (January 2010)

Volume 75, Issue 1, Pages (January 2009)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

Acute myocardial infarction in patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants1 Lyndsay S. Baines, John T. Joseph,

Volume 70, Issue 12, Pages (December 2006)

Fructose intake as a risk factor for kidney stone disease

Response to ‘Hepcidin levels in patients with renal disease’

Volume 54, Issue 6, Pages (January 1998)

Volume 87, Issue 1, Pages (January 2015)

Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske

Volume 93, Issue 1, Pages (January 2018)

Thomas Mueller, Benjamin Dieplinger Kidney International

The global challenge of chronic kidney disease

Nephrology Crossword: Glomerulonephritis

Unilateral renal cystic disease

A man with a hole in his penis

The treatment of acute interstitial nephritis: More data at last

Volume 79, Issue 5, Pages (March 2011)

Carmine Zoccali, Francesca Mallamaci Kidney International

Organ transplantation goes to the movies

Nina Vasavada, Rajiv Agarwal Kidney International

Volume 55, Pages S3-S16 (June 1999)

The Danish Renal Biopsy Register

Robert G. Nelson, Hal Morgenstern, Peter H. Bennett

Volume 56, Issue 2, Pages (August 1999)

The hypothesis that abnormal BH4 metabolism impairs kidney function

Is complement a target for therapy in renal disease?

Volume 70, Issue 5, Pages (September 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Hisataka Kobayashi, Peter L. Choyke Kidney International

T cells and T-cell receptors in acute renal failure

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors Lynn Stothers, William A. Gourlay, Li.

Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund

Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases Martina Franz, Wolfgang Woloszczuk,

Volume 68, Issue 4, Pages (October 2005)

Characteristics of sudden death in hemodialysis patients

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Volume 67, Issue 1, Pages 278-284 (January 2005) B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison Christian Mueller, Kirsten Laule-Kilian, Andra Scholer, Charly Nusbaumer, Thomas Zeller, Daniel Staub, Andra P. Perruchoud, Dr Kidney International Volume 67, Issue 1, Pages 278-284 (January 2005) DOI: 10.1111/j.1523-1755.2005.00079.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Cumulative frequency distribution curve displaying the time to discharge of patients with or without kidney disease in the B-type natriuretic peptide (BNP) group versus the control group. BNP testing exclusively reduced the time to discharge in patients without kidney disease. Kidney International 2005 67, 278-284DOI: (10.1111/j.1523-1755.2005.00079.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Total treatment cost in the control group versus the B-type natriuretic peptide (BNP) group in patients with and without kidney disease. BNP testing exclusively reduced total treatment cost in patients without kidney disease. Boxes show means and I bars represent 95% confidence intervals. Kidney International 2005 67, 278-284DOI: (10.1111/j.1523-1755.2005.00079.x) Copyright © 2005 International Society of Nephrology Terms and Conditions